Document is current

Any future updates will be listed below

Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic

Crossref DOI link: https://doi.org/10.1007/s13555-021-00499-8

Published Online: 2021-03-05

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark